INTERPACE BIOSCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
INTERPACE BIOSCIENCES, INC. (IDXG) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $110.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2026-03-30
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-12-31 was $23.00K, a 77.45% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-09-30 was $105.00K, a 74.01% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-06-30 was $7.00K.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-03-31 was -$25.00K, a 125.51% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2025 was $110.00K, a 79.89% decline from fiscal 2024.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2024 was $547.00K, a 20.15% decline from fiscal 2023.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2023 was $685.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $128.00K derived: sum of 2 quarters · filed 2026-03-30 | $135.00K derived: sum of 3 quarters · filed 2026-03-30 | $110.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $112.00K derived: sum of 2 quarters · filed 2025-11-12 | $87.00K 10-Q · filed 2025-11-12 | $189.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$18.00K 10-Q · filed 2025-08-07 | $84.00K derived: sum of 3 quarters · filed 2025-08-07 | $488.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | -$25.00K 10-Q · filed 2025-05-08 | $77.00K derived: sum of 2 quarters · filed 2025-05-08 | $481.00K derived: sum of 3 quarters · filed 2025-05-08 | $424.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $506.00K derived: sum of 2 quarters · filed 2025-03-31 | $449.00K derived: sum of 3 quarters · filed 2025-03-31 | $547.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $347.00K derived: sum of 2 quarters · filed 2024-11-08 | $445.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $41.00K 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $98.00K 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $685.00K 10-K · filed 2024-04-01 |